<?xml version="1.0" encoding="utf-8"?>
<feed xmlns="http://www.w3.org/2005/Atom">
<title>Legal Insider Trading Data | Free and Professional Subscription Services | Insider Insights</title>
<link href="http://www.insiderinsights.com/news/company/nams" ></link>
<id>urn:uuid:90b5a0ea-8ca1-4922-7adb-01b8655ee8ca</id>
<updated>2026-10-04T20:00:25-04:00</updated>
<author>Jonathan Moreland</author>
<subtitle>Profit from legal insider trading. InsiderInsights.com provides free insider trading data tools and resources, and professional grade subscription based real time Form 4 data, analysis and services</subtitle>
<entry>
<title>NAMS: KASTELEIN JOHANNES JACOB PIETER (DIR) Sold (AS) 50,246 Shares of NEWAMSTERDAM PHARMA CO N V for $25.03 on 9/30</title>
<link href="http://www.insiderinsights.com/company/nams/newamsterdam-pharma-co-n-v/id-6476318" ></link>
<id>urn:uuid:5c41dad1-4221-d7a6-e5ff-28e59a818709</id>
<updated>2026-10-02T16:30:31-04:00</updated>
<summary type="html" ><![CDATA[NEWAMSTERDAM PHARMA CO N V (NAMS). Recent Price: $23.20. Mkt Cap:2.7B. 10D Vol: 2.1mm]]></summary>
</entry>
<entry>
<title>NAMS: KASTELEIN JOHANNES JACOB PIETER (DIR) Acquired (JB) 50,246 Shares of NEWAMSTERDAM PHARMA CO N V for $0.00 on 9/30</title>
<link href="http://www.insiderinsights.com/company/nams/newamsterdam-pharma-co-n-v/id-6476319" ></link>
<id>urn:uuid:6da5a1fe-1640-d556-e627-4fb83c197c32</id>
<updated>2026-10-02T16:30:31-04:00</updated>
<summary type="html" ><![CDATA[NEWAMSTERDAM PHARMA CO N V (NAMS). Recent Price: $23.20. Mkt Cap:2.7B. 10D Vol: 2.1mm]]></summary>
</entry>
<entry>
<title>NAMS: DAVIDSON MICHAEL H (CEO,DIR) Bought (B) 10k Shares of NEWAMSTERDAM PHARMA CO N V for $22.65 on 9/14</title>
<link href="http://www.insiderinsights.com/company/nams/newamsterdam-pharma-co-n-v/id-6469188" ></link>
<id>urn:uuid:16f1e51a-9ff6-b4a0-8f91-307888fbc31c</id>
<updated>2026-09-15T16:30:04-04:00</updated>
<summary type="html" ><![CDATA[NEWAMSTERDAM PHARMA CO N V (NAMS). Recent Price: $23.20. Mkt Cap:2.7B. 10D Vol: 2.1mm]]></summary>
</entry>
<entry>
<title>NAMS: SMITHER JOHN W (DIR) Sold (S) 1,600 Shares of NEWAMSTERDAM PHARMA CO N V for $25.32 on 9/4</title>
<link href="http://www.insiderinsights.com/company/nams/newamsterdam-pharma-co-n-v/id-6466765" ></link>
<id>urn:uuid:e7a15669-027c-0413-477d-7760d666dbd9</id>
<updated>2026-09-09T16:30:03-04:00</updated>
<summary type="html" ><![CDATA[NEWAMSTERDAM PHARMA CO N V (NAMS). Recent Price: $23.20. Mkt Cap:2.7B. 10D Vol: 2.1mm]]></summary>
</entry>
<entry>
<title>NAMS: GUNNING ROBERT WILLIAM (VP,CT) Acquired (JB) 3,200 Shares of NEWAMSTERDAM PHARMA CO N V for $0.00 on 9/1</title>
<link href="http://www.insiderinsights.com/company/nams/newamsterdam-pharma-co-n-v/id-6465227" ></link>
<id>urn:uuid:9ecdf09d-8bd1-6e3d-8e48-30f96384702c</id>
<updated>2026-09-03T16:30:05-04:00</updated>
<summary type="html" ><![CDATA[NEWAMSTERDAM PHARMA CO N V (NAMS). Recent Price: $23.20. Mkt Cap:2.7B. 10D Vol: 2.1mm]]></summary>
</entry>
<entry>
<title>NAMS: KASTELEIN JOHANNES JACOB PIETER (DIR) Sold (AS) 125k Shares of NEWAMSTERDAM PHARMA CO N V for $26.91 on 8/24</title>
<link href="http://www.insiderinsights.com/company/nams/newamsterdam-pharma-co-n-v/id-6459895" ></link>
<id>urn:uuid:7004af28-6aba-dc15-e63c-c7707bbea6ea</id>
<updated>2026-08-25T16:30:07-04:00</updated>
<summary type="html" ><![CDATA[NEWAMSTERDAM PHARMA CO N V (NAMS). Recent Price: $23.20. Mkt Cap:2.7B. 10D Vol: 2.1mm]]></summary>
</entry>
<entry>
<title>NAMS: KASTELEIN JOHANNES JACOB PIETER (DIR) Acquired (JB) 125k Shares of NEWAMSTERDAM PHARMA CO N V for $0.00 on 8/24</title>
<link href="http://www.insiderinsights.com/company/nams/newamsterdam-pharma-co-n-v/id-6459896" ></link>
<id>urn:uuid:b7b93680-29c7-5b35-f69d-f65dd6a27f20</id>
<updated>2026-08-25T16:30:07-04:00</updated>
<summary type="html" ><![CDATA[NEWAMSTERDAM PHARMA CO N V (NAMS). Recent Price: $23.20. Mkt Cap:2.7B. 10D Vol: 2.1mm]]></summary>
</entry>
<entry>
<title>NAMS: GUNNING ROBERT WILLIAM (VP,CT) Filed a Form 3, Becoming a Registered Insider at NEWAMSTERDAM PHARMA CO N V With Initial  Holdings of 0</title>
<link href="http://www.insiderinsights.com/company/nams/newamsterdam-pharma-co-n-v/id-6454001" ></link>
<id>urn:uuid:50f219eb-5f31-fb98-89fa-52eb1ec93bc2</id>
<updated>2026-08-14T16:07:03-04:00</updated>
<summary type="html" ><![CDATA[NEWAMSTERDAM PHARMA CO N V (NAMS). Recent Price: $23.20. Mkt Cap:2.7B. 10D Vol: 2.1mm]]></summary>
</entry>
<entry>
<title>NAMS: KOOIJ LOUISE FREDERIKA (CAO) Exercised 105k Options (OE) of NEWAMSTERDAM PHARMA CO N V for $11.17 on 7/20, and Sold Them All</title>
<link href="http://www.insiderinsights.com/company/nams/newamsterdam-pharma-co-n-v/id-6443941" ></link>
<id>urn:uuid:079d2c03-67f1-4f94-5926-26871ed32c79</id>
<updated>2026-07-22T16:05:04-04:00</updated>
<summary type="html" ><![CDATA[NEWAMSTERDAM PHARMA CO N V (NAMS). Recent Price: $23.20. Mkt Cap:2.7B. 10D Vol: 2.1mm]]></summary>
</entry>
</feed>